Real-time medical imaging systems developer Novadaq Technologies recently appointed Dr. David C. Martin as Vice President, Business Development and Investor Relations.
Prior to joining Dr. Martin worked for more than 10 years as a highly ranked healthcare analyst and investment banker with Dundee Securities and Yorkton Securities. Before that, he worked in sales and marketing for clinical diagnostics and biotechnology instrumentation companies, including Boehringer Mannheim and InterScience Inc.
Dr. Martin has a Ph.D. (Biochemistry) from the University of Western Ontario, a M.Sc. (Biology) from the University of Toronto, and an MBA from the Richard Ivey School of Business.